المؤلفون: Valdera FA; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas, USA., O'Shea AE; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas, USA., Smolinsky TR; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas, USA., Carpenter EL; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas, USA., Adams AA; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas, USA., McCarthy PM; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas, USA., Tiwari A; Department of Surgery, University of Texas San Antonio Health Science Center, San Antonio, Texas, USA., Chick RC; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas, USA., Kemp-Bohan PM; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas, USA., Van Decar S; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas, USA., Thomas KK; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas, USA., Bader JO; Cancer Insight, LLC, San Antonio, Texas, USA., Peoples GE; Cancer Insight, LLC, San Antonio, Texas, USA., Clifton GT; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas, USA., Stojadinovic A; Cancer Insight, LLC, San Antonio, Texas, USA., Nelson DW; Department of Surgery, William Beaumont Army Medical Center, El Paso, Texas, USA., Vreeland TJ; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas, USA.

المصدر: Journal of surgical oncology [J Surg Oncol] 2024 Feb; Vol. 129 (2), pp. 244-253. Date of Electronic Publication: 2023 Oct 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/drug therapy , Pancreatic Neoplasms*/surgery , Pancreatic Neoplasms*/pathology , Adenocarcinoma*/pathology, Humans ; Chemotherapy, Adjuvant ; Neoadjuvant Therapy ; Proportional Hazards Models ; Retrospective Studies

المؤلفون: McCarthy PM; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, United States., Valdera FA; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, United States., Smolinsky TR; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, United States., Adams AM; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, United States., O'Shea AE; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, United States., Thomas KK; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, United States., Van Decar S; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, United States., Carpenter EL; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, United States., Tiwari A; Department of Surgery, University of Texas Health Science Center, San Antonio, TX, United States., Myers JW; Department of Surgery, Madigan Army Medical Center, Ft. Lewis, WA, United States., Hale DF; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, United States., Vreeland TJ; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, United States., Peoples GE; Cancer Insight, San Antonio, TX, United States., Stojadinovic A; Cancer Insight, San Antonio, TX, United States., Clifton GT; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, United States.

المصدر: Frontiers in immunology [Front Immunol] 2023 Mar 07; Vol. 14, pp. 1090533. Date of Electronic Publication: 2023 Mar 07 (Print Publication: 2023).

نوع المنشور: Systematic Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines*/therapeutic use , Neoplasms*/therapy , Neoplasms*/pathology, Humans ; Lymphocytes, Tumor-Infiltrating ; Immunotherapy ; Tumor Microenvironment

المؤلفون: O'Shea AE; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA., Valdera FA; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA. Electronic address: fvalderajr@gmail.com., Ensley D; Department of Urology, Brooke Army Medical Center, Ft. Sam Houston, TX, USA., Smolinsky TR; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA., Cindass JL; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA., Kemp Bohan PM; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA., Hickerson AT; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA., Carpenter EL; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA., McCarthy PM; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA., Adams AM; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA., Vreeland TJ; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA; Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Clifton GT; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA; Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Peoples GE; Cancer Insight, San Antonio, TX, USA.

المصدر: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2022 Dec; Vol. 245, pp. 109095. Date of Electronic Publication: 2022 Aug 13.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 100883537 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-7035 (Electronic) Linking ISSN: 15216616 NLM ISO Abbreviation: Clin Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/prevention & control , Neoplasms*/drug therapy , Sirolimus*/pharmacology , Sirolimus*/therapeutic use, Humans ; Chemoprevention ; Immunosuppressive Agents/pharmacology ; TOR Serine-Threonine Kinases/metabolism